Skip to main content

Advertisement

Log in

The prevalence of rheumatoid arthritis in Estonia: an estimate based on rheumatology patients’ database

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Sound epidemiological data are a basic requirement for decision making on the allocation of health care resources. Unfortunately, this is not the case in Estonia, where the paucity of epidemiological data has impeded health care planning for rheumatic conditions. The current paper presents the first effort to explore the epidemiology of rheumatoid arthritis (RA) in Estonia. Electronic databases of all rheumatology units of Harju County, three national and one private, were searched for the records of RA (ICD-10 diagnoses M05 and M06.0) patients who had visited a rheumatologist during 2006 or 2007. Prevalence of RA was calculated for the age 20 years and older and for subsets according to age and gender, using the numbers from the patients’ database in the numerator and the corresponding population numbers in the denominator. The total number of prevalent RA cases was 1,897, of which 85 % (n = 1,605) were women. The overall crude period prevalence 2006–2007 of RA in Harju County for the age group 20 years and older was 0.46 %. RA prevalence for both sexes increased with age until the age of 70–79 years and decreased subsequently. Prevalence of RA was significantly higher for women compared with men in all age groups. The prevalence of RA among women and men 20 years and older was 0.70 % (6.68–7.37) and 0.16 % (1.42, 1.79), respectively. Age-standardized (European population) prevalence rate was 0.44 %. The results are concordant with epidemiological data on RA prevalence derived recently in other European countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Valter I, Saretok S, Maricq HR (1997) Prevalence of scleroderma spectrum disorders in the general population of Estonia. Scand J Rheumatol 26(6):419–425

    Article  PubMed  CAS  Google Scholar 

  2. Valter I, Maricq HR (1997) Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia. Scand J Rheumatol 26(2):117–124

    Article  PubMed  CAS  Google Scholar 

  3. Valter I, Maricq HR (1998) Prevalence of Raynaud’s phenomenon in 2 ethnic groups in the general population of Estonia. J Rheumatol 25(4):697–702

    PubMed  CAS  Google Scholar 

  4. Pruunsild C, Uibo K, Liivamagi H, Tarraste S, Talvik T, Pelkonen P (2007) Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia. Clin Exp Rheumatol 25(4):649–653

    PubMed  CAS  Google Scholar 

  5. Pruunsild C, Uibo K, Liivamagi H, Tarraste S, Talvik T, Pelkonen P (2007) Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol 36(1):7–13

    Article  PubMed  CAS  Google Scholar 

  6. Tammaru M, Polluste K, Lember M (2010) The sources of disease-related information for Estonia’s rheumatoid arthritis patients: a qualitative study. J Clin Nurs 19(9–10):1343–1351

    Article  PubMed  Google Scholar 

  7. Peets T (2003) Reumatoidartriidi ravijuhend Eestis. Estonian Society for Rheumatologists [Rheumatoidarthritis treatment guidelines in Estonia] (in Estonian)

  8. Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324

    Article  PubMed  CAS  Google Scholar 

  9. Statistics Estonia. Population figures for Estonia. Available at. http://pub.stat.ee/px-web.2001/I_Databas/Population/01Population_indicators_and_composition/04Population_figure_and_composition/04Population_figure_and_composition.asp. Accessed 07 Sept 2011

  10. European Standard Population. Extract from compendium of clinical and health indicators user guide national centre for health outcomes development. Available at. http://www.nchod.nhs.uk/NCHOD/Method.nsf/0/19bd7f5d961a822f65256cd2001eae50/$FILE/Compendium%20User%20Guide%202005%20Apr%20Annex%205%20V1.doc. Accessed 02 Sept 2011

  11. Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American college of rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188

    Article  PubMed  Google Scholar 

  12. Kvien TK, Glennas A, Knudsrod OG, Smedstad LM, Mowinckel P, Forre O (1997) The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 26(6):412–418

    Article  PubMed  CAS  Google Scholar 

  13. Kobelt G, Kasteng F (2009) Access to innovative treatments in rheumatoid arthritis in Europe. A report prepared for the European Federation of Pharmaceutical Industry Associations (EFPIA) 2009

Download references

Acknowledgments

This study was supported by the following grant: K. Otsa, MERCK, IISP ID#:35016 Grant Research Support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Lang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Otsa, K., Tammaru, M., Vorobjov, S. et al. The prevalence of rheumatoid arthritis in Estonia: an estimate based on rheumatology patients’ database. Rheumatol Int 33, 955–958 (2013). https://doi.org/10.1007/s00296-012-2473-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2473-6

Keywords

Navigation